Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 41446 [E9-19583]
Download as PDF
41446
Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the twentieth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to approximately 6 p.m. on
Thursday, October 8, 2009, and from 8
a.m. to approximately 3:30 p.m. on
Friday, October 9, 2009, at the Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
The meeting will be open to the public
with attendance limited to space
available. The meeting also will be Web
cast.
The main agenda items involve the
review of three SACGHS draft reports: a
final draft report and its
recommendations on gene patents and
licensing practices along with
comments received on the public
consultation draft circulated earlier this
year; a public consultation draft report
on genetics education and training; and
a revised draft paper on direct-toconsumer genetic testing. The first day
of the meeting will include an extended
period of time for interested members of
the public to provide their perspectives
on gene patents and licensing practices
and their effect on patient access to
genetic tests. Members of the public are
encouraged to contact the SACGHS
Executive Secretary (see below) by
September 15, 2009, if they wish to
participate in this extended public
comment period. Other agenda items
include an update on regulations
implementing the Genetic Information
Nondiscrimination Act, a report on
activities of the Clinical Utility and
Comparative Effectiveness Task Force,
and a brief discussion to initiate the
Committee’s work on ethical issues
related to genomic data sharing.
As always, the Committee welcomes
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment should notify the SACGHS
Executive Secretary, Ms. Sarah Carr, by
telephone at 301–496–9838 or e-mail at
carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892. Anyone
planning to attend the meeting who
needs special assistance, such as sign
language interpretation or other
VerDate Nov<24>2008
17:55 Aug 14, 2009
Jkt 217001
reasonable accommodations, is also
asked to contact the Executive
Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
oba.od.nih.gov/SACGHS/
sacghs_meetings.html.
Dated: August 10, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19583 Filed 8–14–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: September 17–18, 2009.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Open: September 17, 2009, 10:30 a.m. to
5:00 p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research and other
Administrative and Program Developments.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: September 18, 2009, 8 a.m. to 11:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19578 Filed 8–14–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
E:\FR\FM\17AUN1.SGM
17AUN1
Agencies
[Federal Register Volume 74, Number 157 (Monday, August 17, 2009)]
[Notices]
[Page 41446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19583]
[[Page 41446]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the
twentieth meeting of the Secretary's Advisory Committee on Genetics,
Health, and Society (SACGHS), U.S. Public Health Service. The meeting
will be held from 8:30 a.m. to approximately 6 p.m. on Thursday,
October 8, 2009, and from 8 a.m. to approximately 3:30 p.m. on Friday,
October 9, 2009, at the Hubert H. Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201. The meeting will be open to the
public with attendance limited to space available. The meeting also
will be Web cast.
The main agenda items involve the review of three SACGHS draft
reports: a final draft report and its recommendations on gene patents
and licensing practices along with comments received on the public
consultation draft circulated earlier this year; a public consultation
draft report on genetics education and training; and a revised draft
paper on direct-to-consumer genetic testing. The first day of the
meeting will include an extended period of time for interested members
of the public to provide their perspectives on gene patents and
licensing practices and their effect on patient access to genetic
tests. Members of the public are encouraged to contact the SACGHS
Executive Secretary (see below) by September 15, 2009, if they wish to
participate in this extended public comment period. Other agenda items
include an update on regulations implementing the Genetic Information
Nondiscrimination Act, a report on activities of the Clinical Utility
and Comparative Effectiveness Task Force, and a brief discussion to
initiate the Committee's work on ethical issues related to genomic data
sharing.
As always, the Committee welcomes hearing from anyone wishing to
provide public comment on any issue related to genetics, health and
society. Individuals who would like to provide public comment should
notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at
301-496-9838 or e-mail at carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone
planning to attend the meeting who needs special assistance, such as
sign language interpretation or other reasonable accommodations, is
also asked to contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic and genomic technologies and, as
warranted, to provide advice on these issues. The draft meeting agenda
and other information about SACGHS, including information about access
to the Web cast, will be available at the following Web site: https://oba.od.nih.gov/SACGHS/sacghs_meetings.html.
Dated: August 10, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory Committee Policy.
[FR Doc. E9-19583 Filed 8-14-09; 8:45 am]
BILLING CODE 4140-01-P